Introduction
Sudden unexpected death in epilepsy (SUDEP) has been defined as 'sudden, unexpected, witnessed or un-witnessed, non-traumatic and non-drowning death in patients with epilepsy, with or without evidence of a seizure and excluding documented status epilepticus, where post-mortem examination does not reveal a toxicological or anatomical cause of death'. 1 No evidence of the mechanisms underlying SUDEP have been proven but alteration of autonomic activity in association with seizures and sub-clinical seizures may lead to cardiac or respiratory instability and is believed to be one the underlying causes of SUDEP. [1] [2] [3] [4] [5] [6] It has also been postulated that a predisposed patient could become a victim of SUDEP if there is a combination of reduced sympathetic tone during sleep, ictal bradyarrthymia or extreme changes in heart rate resulting in autonomic instability. Ictal bradyarrthmia and/or sinus arrest have vagally mediated involvement during seizure discharges. 7 Autonomic manifestations during seizures are common. However, it is not possible to quantify the effects of cardiac vagal tone and heart rate variability during most clinical seizures as changes in consciousness, body position and physical exertion all alter sympatho-vagal balance. Therefore, the aim of this study is to investigate changes in cardiac vagal tone and heart rate variability during sub-clinical seizures. Sub-clinical seizures have been defined as ''electroencephalographic ictal-like patterns without any disturbance of motor, sensory and conscious functions in the wake patient and without any movement or arousal during the sleep patient''. 8 Beat to beat variation of heart rate is partly due to influences of the autonomic nervous system innervating the sinus node. Loss of this variation is widely considered to be a measure for risk of sudden death in myocardial infarction patients.
measuring baroreflex cardiac vagal tone and BioSignal HRV measuring tonic vagal activity. The NeuroScope 13 measures cardiac vagal tone by analysing R-R interval measurements and comparing incoming QRS signal to a previously acquired QRS template. This innovative device measures the delay in the next cardiac cycle induced by baroreceptor stimulation, which is proportional to baroreceptor strength and duration. 14 Since the NeuroScope quantifies the effects of the baroreflex on the pulse intervals on a beat-by-beat basis, it can output a cardiac index of parasympathetic activity (CIPA) as real-time measurements of reflex vagal activity. CIPA is defined as ''the increase in pulse interval per unit increase in systolic pressure'' 15 and measured on an arbitrary scale of 1-10 based on studies of supine resting healthy adults in response to atropine and uses a zero reference point. An output measurement of 1-4 units represents low cardiac index of parasympathetic activity (CIPA) and 5-10 units represents the normal range of CIPA in adults. 16 However, a review article by
McKechnie et al. 17 suggested that the upper limit of normal CIPA should be extended. BioSignal 18 heart rate variability (HRV) analysis is the comparison of sequential R-R intervals and changes in interval are plotted in the time domain as a tachogram. The time domain R-R interval tachogram is then digitally interpolated for spectrum estimation as a frequency domain. This is displayed separately for Welch's Periodogram fast Fourier transform (FFT) and an autoregressive modelling based spectrum (AR). Frequency oscillations are quantified and displayed as a power spectral density once any leakage current frequencies are removed using a Hamming window filter. A power spectral density of very low frequency (VLF, 0-0.04 Hz), low frequency (LF, 0.04-0.15 Hz) and high frequency (HF, 0.15-0.4 Hz) is produced. LF is believed to be a mixture of sympathetic and parasympathetic activity and is therefore difficult to interpret. %HF will be considered in this study, as HF is believed to be a measure of mainly parasympathetic tonic vagal activity. 19 
Materials and methods
Patients who were already familiar with video-EEG/ECG/SAO2 telemetry and not anxious about the test were invited to take part in this ethically approved prospective study over a 24-month period (Table 1 ). In patients who had sub-clinical seizures, strict criteria ensured that selected sub-clinical data and baseline data were restricted to stage 3 or 4 sleep 20, 21 or ''N3'' or ''N4''stages as defined by the American Academy of Sleep Medicine reported by Iber et al. 22 A constant resting slow wave sleep state during stages 3 and 4 was chosen to compare baseline and sub-clinical seizure parasympathetic activity during regular respiration. Control data was obtained using each patient's baseline measurements to compare to the sub-clinical seizure data during the same stage of slow wave sleep. Drowsiness or light sleep was considered to be too brief and REM sleep was avoided as withdrawal of vagal tone is described during REM sleep particularly in men. 23 Sub-clinical seizures were identified electrographically from 23 scalp electrodes placed in accordance to the International 10:20 system and verified as having no clinical accompaniment by high resolution time-integrated video. Electroencephalography was also used to identify slow wave sleep and that the trace was void of arousals or movement. Manual selection of R-R interval sections ensured that the trace was artefact free and any ectopic beats were excluded. The sampling rate of the physiological ECG signal was 500 Hz and 5 kHz post acquisition by the NeuroScope. All patients were in sinus rhythm throughout. No patients were known to have diabetes or coronary heart disease that may alter HRV findings. Oxygen saturation was measured using an LNOP forehead Masimo sensor with a digital signal output 1/s displayed simultaneously with the EEG/ECG telemetry trace.
Video-EEG/ECG/SAO2 telemetry data for NeuroScope analysis
The start of the ECG sample was taken 1-min prior to the subclinical electrographic change to ensure that any cardiac vagal tone changes just prior to sub-clinical seizure onset were not omitted. The end of the sample was taken when the sub-clinical seizure ended electrographically and the resting trace was resumed. R-R intervals were counted manually for each study and a matched count was selected from the resting record in sleep stages 3 or 4 from the same patient as control baseline measurements for the comparison of sub-clinical seizure data.
Electrocardiographic conversion for NeuroScope analysis
Clipped EEG/ECG telemetry data of the selected sub-clinical seizures and matched counted EEG/ECG baseline data were standards state that 5-min epochs should be analysed for 'short term' HRV. Each section of R-R interval previously measured for CIPA NeuroScope analysis during sub-clinical seizures and baseline measurements were embedded within a 5-min clipped sample to enable BioSignal HRV analysis. As sub-clinical seizures tend to be much briefer than 5 min the sample also included some resting and post-ictal phase data. R-R intervals were manually measured from these files and entered onto an Excel spreadsheet. These Excel spreadsheets were then converted to Text (MSDOS) files and imported into BioSignal HRV software for analysis.
Statistical analysis
Statistical analyses of total CIPA sub-clinical seizure data was compared with total baseline data using Minitab version 14. Tailed distribution of total data meant that non-parametric analysis was required using Wilcoxon paired sample testing. Co-efficient of variation is a normalised measure of dispersion or scatter and was used to analyse the dispersion of data in CIPA in right and left temporal lobe sub-clinical seizures and generalised sub-clinical seizures. The results were corrected for multiple measurements using Bonferroni correction. BioSignal biomarkers of HF, LF, VLF, SDNN (Standard Deviation of Normal-to-Normal Beat), SDNN50 (Standard Deviation of Normal-to-Normal beat 50 millisecond count) and RMSSD (Root Mean Square of Successive Differences) sub-clinical measurements were compared to baseline measurements. Data for temporal lobe sub-clinical seizures was compared with that for generalised sub-clinical seizures. Limits of agreement were calculated using Bland and Altman plot 24, 25 defined as the mean difference AE twice the standard deviation of the differences.
Inter and intra-observer agreement of manual R-R measurement for 5-min HRV were analysed using students paired t-tests.
Results
Thirty-three sub-clinical seizures (mean duration 191.1 AE 136.4 s, ranging from 63 to 340 s) were analysed from 11 patients with an age range 3 years 1 month to 60 years 3 months (mean age 23.09 AE 18.73 years). The 11 patients were selected from 50 patients who took part in a larger physiological study. The remaining 39 patients either did not have sub-clinical seizures or have sub-clinical seizures that did not occur during slow wave sleep and therefore could not be included in the study. Six patients were adults (3 male and 3 female, mean age 35.81 AE 15.99 years) and 5 patients were paediatric (4 male and 1 female, mean age 7.81 AE 4.8 years). Nine sub-clinical seizures were derived from and confined to the right temporal lobe (5 patients: 3 adults -3 seizures and 2 children -6 seizures) and five sub-clinical seizures were derived from and confined to the left temporal lobe (4 patients: 3 adults -3 seizures and 1 child -2 seizures). Nineteen generalised sub-clinical seizures were analysed from two paediatric patients. HFms 2 represents high frequency power but using this unit of measurement resulted in large variations in values with substantial standard deviations and were hard to quantify and compare for both inter and intra-subject data. CIPA, HF% and HFms 2 were tested using a Pearson correlation co-efficient. CIPA results were more closely correlated to HF% (p < 0.001) than HFms 2 (p = 0.359).
Therefore HF% is described in this study instead, measuring the proportion of high frequency HRV in relation to low frequency and very low frequency. No changes in oxygen saturation were detected during sub-clinical seizures.
NeuroScope CIPA
A decrease in CIPA indicates reduced vagal tone and usually results in an increase in heart rate and vice versa. (Fig. 4 ). An increase in coefficient of variation is also seen from sub-clinical seizures arising from the left temporal lobe of 44.4% (CI 12.7, 76.0) increasing from baseline measurements (29.4% CI 7.8, 50.9) (Fig. 4) . Conversely, the co-efficient of variation difference from generalised (Fig. 4) . 
Comparison of adult data and paediatric data

BioSignal SDNN50
When SDNN50 mean counts are considered for all patients there is no significant difference between total baseline counts (65.9 AE 76.3) and sub-clinical seizure (64.5 AE 58.2) data (p = 0.932). However, differences are detected when sub-clinical seizure types are analysed separately. There are generally smaller counts during baseline and sub-clinical seizure counts for patients with refractory generalised epilepsy compared to analysis of counts for patients with temporal lobe seizures. Baseline mean counts of SDNN50 for right temporal subclinical seizures for baseline measurements (133.
SDNN and RMSSD
SDNN is the square root of variance and is mathematically equal to the total power of spectral analysis and represents all the cyclic components contributing to HRV. 19 VLF% HRV physiological representation is largely unexplained but considered to be indicative of rennin-angiotensin-aldosterone hormonal interplay on the autonomic nervous system. No statistically significant results are seen from changes in this spectral frequency.
Effects of anti-epileptic medication on CIPA
No statistically significant differences in CIPA are found when comparing baseline to sub-clinical seizure results from patients being treated by anti-epileptic medication (p = 0.407) with those who were not receiving any anti-epileptic medication (p = 0.658). Seven patients (3 adults, 4 paediatrics) receiving monotherapy (3 patients) and polytherapy (4 patients) had similar baseline CIPA measurements (3.83 AE 2.94) compared to four patients (3 adults, 1 paediatric) not receiving anti-epileptic medication (3.43 AE 1.68).
Inter and intra-observer agreement
Inter-observer agreement of identical R-R measurements (n = 369) was highly correlated with no statistical significant difference between observers (p = 0.809). Intra-observer agreement of identical R-R measurements was even more closely correlated and again no statistical significant difference found between runs of observations (p = 0.976).
Discussion
'The last two decades have witnessed the recognition of a significant relationship between the autonomic nervous system and cardiovascular mortality, including sudden cardiac death. Experimental evidence for an association between the propensity for lethal arrhythmias and signs of either increased sympathetic or reduced vagal activity has spurred efforts for the development of quantitative markers of autonomic activity. Heart rate variability represents one of the most promising such markers'. 19 The ''lockstep phenomenon'' was proposed by Lathers et al. 26 and proved synchronisation between epileptogenic ''sub-convulsant'' discharges with abnormal sympathetic and vagal neural discharges with cardiac arrhythmia in anaesthetised cats. They suggested that the lockstep phenomenon of synchronisation of epileptogenic discharge with cardiac sympathetic neural discharge could be a contributing factor of SUDEP. Variability of successive R-R intervals is generally considered to be an important protective mechanism of the autonomic nervous system being able to respond to sudden cardiovascular demands. 12, 27 Loss of this variability increases the risk of sudden cardiac death and reduced HRV is a measure of risk stratification for myocardial infarction patients. [9] [10] [11] [12] Bigger et al. 9 describe sudden cardiac death occurring within 2.5 years post myocardial infarction for approximately 50% of patients. The Framingham Heart Study reported by Tsuji et al. 28 indicates that low HRV is an independent marker of all causes of mortality in coronary events. Bilchick and Berger 29 reviewed HRV literature and described results from the Multicenter Post infarction Group (1987) that SDNN was the strongest univariant predictor of mortality from reduced HRV culminating from a combination of sustained increased sympathetic tone and vagal withdrawal, increasing the risk of ventricular fibrillation. Clear altered parasympathetic activity is observed in this pilot study for whole group analysis when comparing sub-clinical seizures data to baseline measurements. There is a decrease in cardiac vagal tone in total sub-clinical seizures (CIPA, p < 0.001 and 5-min HF%, p = 0.026). One previous study, 30 reported ''minimal'' changes of ''lower HRV'' from left sub-clinical seizures than from right sub-clinical seizures. However, the study by this group is methodologically limited as 10-s epochs for HRV and is considered too short to quantify HRV fully unless vagal tone is measured using the NeuroScope. 31 Additionally, the SDNN was calculated over 10 s, which is also too brief a duration to perform this time domain analysis effectively. As the period of monitoring decreases, SDNN will estimate a shorter cycle length and for this reason the minimum European standard period of monitoring is 5 min. 
CIPA versus HRV
CIPA measures efferent vagal tone from baroreceptor feedback and HRV HF measures modulations of parasympathetic tonic activity. Bigger et al. 32 found only a moderate correlation between heart rate variability and baroreflex sensitivity. Barron and Lesh 33 explain that this is expected because baroreflex sensitivity is a ''vagal stress test'' measuring transient changes on a beat by beat basis compared to summated tonic activity over 24-h periods (divided into 5-min epochs). A large prospective study, 34 found that Baroreflex sensitivity and SDNN have similar prognostic values but are stronger when used in combination.
4.2. Do generalised sub-clinical seizures pose a greater risk of autonomic nervous system deregulation than temporal lobe seizures?
In this pilot study, there are statistically significant increases in cardiac vagal tone, smaller changes in overall HRV (SDNN), short term HRV (RMSSD), and lower counts of SDNN50 in generalised sub-clinical seizures compared to sub-clinical seizures arising from the temporal lobes. Persson et al. 35 analysed long term resting 24-h HRV of 22 newly diagnosed patients with epilepsy prior to treatment with a control group and found no statistically significant differences between the two groups. However, repeated seizures over a longer term are reported to have an effect on autonomic cardiac regulation and patients with chronic epilepsy have an increased morbidity and higher rates of SUDEP mortality than patients with newly diagnosed epilepsy. 36, 37 Harnod et al. 37 analysed heart rate variability in children with refractory generalised epilepsy and they concluded that lower HRV was found during the inter-ictal period. Bulent et al. 38 also describe how long term abnormalities in the autonomic nervous system from repeated seizures can cause a temporary impairment in autonomic functions by each epileptic discharge having an effect upon limbic structures, amygdala and periamygdaloid piriform cortex. Additionally, this group found that autonomic dysfunction became more marked in the post-ictal period compounding an already existing dysfunction. Nouri et al. 39 describes how damage to the myocardium can occur when exposed to frequent increases of plasma catecholamines. This damage to the myocardium can then cause areas of fibrosis and render the myocardium more likely to trigger cardiac arrhythmias. During epileptic seizures, tachycardia is common due to vagal withdrawal and sympathetic catecholamic release. Repeated seizures caused by refractory epilepsy may theoretically also lead to damage to the myocardium and result in reduced HRV and be more prone to cardiac arrhythmias. Both patients presenting with generalised sub-clinical seizures in this study had severe intractable epilepsy and proposed effects of repeated seizures on the autonomic nervous system 36,37 may be a contributing factor of increased cardiac vagal tone and reduced HRV compared to localisation related epilepsy patients in this study. La Rovere et al. 34 commented that patients who have low vagal tone have a reduced capability to antagonise sympathetic activation through vagal mechanisms and describe a peak in mortality during early morning hours when there is a surge of sympathetic activity. This may be a contributing factor during fatal nocturnal seizures. Concordant with Evrengul et al. 36 and Harnod et al. 37 this study demonstrates a lower inter-ictal or ''baseline'' HRV HF% in patients with generalised epilepsy compared to patients with temporal lobe seizures. R-R interval data during generalised subclinical seizures is different compared with R-R interval data during right or left temporal lobe sub-clinical seizures. Generalised sub-clinical seizures show a mean increase in R-R interval from 628.9 to 686.9 ms (p < 0.001) indicating a decrease in heart rate. Decreases in R-R coefficient of variation occurs during generalised sub-clinical seizures (5% baseline to 4.3% subclinical), compared to increases in coefficient of variation of R-R interval during right temporal lobe sub-clinical seizures (7.3% baseline to 10.6%) and R-R interval data during left temporal lobe sub-clinical seizures (8.6% baseline to 15.8%) demonstrate that decreased HRV occurs during generalised sub-clinical seizures but is not found during sub-clinical seizures arising from temporal lobes.
A proposed SUDEP mechanism
Autonomic instability and reduced variability of successive beats may put a pre-disposed individual at more risk of cardiac arrhythmia during sleep in the event of a seizure when vagal tone is already high. 40 During a seizure, it would be expected that the autonomic nervous system responds by decreasing vagal tone and increasing heart rate ready to meet the physical demands of the seizure. However, this study would indicate that in some cases of generalised seizures there could instead be an inappropriate initial further increase in vagal tone resulting in a further initial decrease in heart rate potentially leading to ictal bradyarrythmia. Clinical generalised seizures are then characteristically followed by a massive acceleration of heart rate and marked catecholaminergic activity at the myocardium. This initial mismatch between vagal tone and seizure demand could make the myocardium vulnerable leading to possible cardiac arrhythmia and then SUDEP in some pre-disposed individuals with low heart rate variability. Massive sympathetic discharge can trigger fatal cardiac arrthythmias during seizures. 39, 41 O'Regan and Brown 42 also describe a rapid but short lived rise in cardiac vagal tone associated with some seizures but consider that this may be an inbuilt mechanism to protect the myocardium from possible fatal cardiac arrhythmias caused by unbridled sympathetic or massive catecholamine activity. Delamont et al. 43 also describe an increase in cardiac parasympathetic activity just prior to secondary generalised complex partial seizures and proposed that pre-ictal elevation of cardiac sympathetic activity may be a marker for secondary generalised seizures. A study by Vaughn et al. 7 recorded asystole lasting 3-17 s during five generalised tonic clonic seizures in an infant. They found increases in both sympathetic and parasympathetic spectral frequencies and therefore suggested epileptic induced asystole resulted from both arms of autonomic outflow being activated. However, it is not clear from Vaughn et al.'s study at which point in the clinical seizure the 10-s epoch was selected, whether artefactfree ECG was possible during a clinical seizure and how interpretation of HRV analysis was possible during a clinical epileptic attack when complicated by physical exertion, change in body position and temperature alteration and only 10 s epochs were selected despite being too short to use in traditional methods of HRV. between scalp electroencephalographic spikes and alteration in the R-R interval at that moment, comparing spike discharges from the right and left hemispheres and found a direct effect of the interictal discharge on the R-R interval. Due to respiratory sinus arrhythmia (RSA) it would have been methodologically improved if R-R intervals were also measured from samples of the recording that did not have any electrographic spike discharges to quantify the effects of RSA. Some patients are considered to be more pre-disposed to cardiac arrhythmia and sudden death than others. A study by Schwartz et al. 45 demonstrated that a group of susceptible post myocardial infarction dogs had reduced baroreflex sensitivity prior to the infarction compared to resistant surviving dogs. La Rovere et al. 34 concluded from a large prospective study 30 days post-infarction that reduced baroreflex sensitivity was a powerful predictor of mortality for these patients over the following 2 years.
Limitations of the study
This pilot study included eleven patients due to strict inclusion criteria. Manual measuring of 27,151 R-R intervals (33 sub-clinical seizures with 5-min matched baselines) also presented time limitations of what was possible during this research period. Automated peak detection software was considered but when checked and re-measured manually, there were marked errors and so manual measurement was preferred. In a report by the American Heart Association, 46 a consortium of European investigators found systematic errors in measurement of 16 computer programs for automated ECG analysis and reported that manual measurement was often more accurate.
Effects of anti-epileptic medication
Ansakorpi et al. 4 did not find any changes in heart rate variability from effects of anti-epileptic medication in their study of temporal lobe epilepsy patients compared to controls but they acknowledge that anti-epileptic medication are anticipated to cause changes in cardiovascular regulatory function in some patients due to blocking of sodium channels. This pilot study also did not find any significant differences in CIPA results when comparing patients who were being treated with anti-epileptic medication to those not being treated with anti-epileptic medication. The possible effects of anti-epileptic medication on vagal tone cannot be fully evaluated due to the small scale of this study.
Age effect on CIPA and HRV HF data
Effect could not be assessed adequately due to the small number of patients included in this study. Normal data for standardised CIPA or HRV have not been sufficiently established in paediatrics in all age ranges. It has been reported 47, 48 that there is an age-related alteration in cardiac vagal tone of an increase in cardiac vagal tone between the ages of 3-6 years and then a decrease from 6 to 15 years. However, numbers of patients included in this normal data are also small and do not give account of the wide intra and inter-subject variation in HRV 49 and these studies did not analyse HRV during specific sleep stages defined electrographically. Generalised data derived from two patients in this study (aged 3 and 5 years) had lower cardiac vagal tone compared to older paediatric patients. The two youngest patients also had severe generalised epilepsy and therefore their data may not be comparable to normal data. Toth et al 50 describe lower HRV in children with refractory epilepsy resulting from parasympathetic tonus reduction and suggest that this may arise from different mechanisms compared to adults. Unfortunately, no generalised sub-clinical seizures in adults were captured. A larger study would be required to ascertain whether adults also show an increase in cardiac vagal tone during generalised sub-clinical seizures as demonstrated by the children with generalised subclinical seizures in this study.
Gender differences
Gender differences are considered unlikely to have made a significant difference to the results of this study because data was not measured during Rapid Eye Movement (REM) stage sleep. A study by Valladares et al. 23 showed the only gender difference in nocturnal vagal tone occurred in men during REM sleep where there was a marked increase in cardiac sympathetic drive. Despite these limitations this study has shown increased parasympathetic activity and lower R-R variability during generalised sub-clinical seizures compared to decreased parasympathetic activity and increased R-R variability during temporal lobe sub-clinical seizures.
Further study
Indications from this pilot study have offered a good basis for further investigation with a large study of the differences between generalised and temporal lobe sub-clinical seizures in the continued investigation of possible autonomic mechanisms of SUDEP. Nouri et al. 39 underlines the importance of evaluating autonomic cardiovascular and respiratory reflexes in people with epilepsy and believes that it will provide invaluable insight into some of the mechanisms of SUDEP. The Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology 19 believe that the task of assessing transient changes in HRV seem to be more important than further refinements of HRV technology. Researchers analysing HRV must use standardised methodology to enable comparisons in results in various diseases and to increase knowledge of clinical consequences.
Conclusion
In this pilot study we have demonstrated an alteration in cardiac reflex and tonic vagal tone during sub-clinical seizures compared to baseline measurements. Further research may bring us closer to understanding the relationship between autonomic dysfunction and SUDEP.
